• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外泌体 miRNAs 在糖尿病中的新兴作用。

Emerging roles of exosomal miRNAs in diabetes mellitus.

机构信息

Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.

Departments of Ultrasound Imaging, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.

出版信息

Clin Transl Med. 2021 Jun;11(6):e468. doi: 10.1002/ctm2.468.

DOI:10.1002/ctm2.468
PMID:34185424
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8236118/
Abstract

Exosomes are small extracellular vesicles 40-160 nm in diameter that are secreted by almost all cell types. Exosomes can carry diverse cargo including RNA, DNA, lipids, proteins, and metabolites. Exosomes transfer substances and information between cells by circulating in body fluids and are thus involved in diverse physiological and pathological processes in the human body. Recent studies have closely associated exosomal microRNAs (miRNAs) with various human diseases, including diabetes mellitus (DM), which is a complex multifactorial metabolic disorder disease. Exosomal miRNAs are emerging as pivotal regulators in the progression of DM, mainly in terms of pancreatic β-cell injury and insulin resistance. Exosomal miRNAs are closely associated with DM-associated complications, such as diabetic retinopathy (DR), diabetic nephropathy (DN), and diabetic cardiomyopathy (DCM), etc. Further investigations of the mechanisms of action of exosomal miRNAs and their role in DM will be valuable for the thorough understanding of the physiopathological process of DM. Here, we have summarized recent findings regarding exosomal miRNAs associated with DM to provide a new strategy for identifying potential diagnostic biomarkers and drug targets for the early diagnosis and treatment, respectively, of DM.

摘要

外泌体是直径为 40-160nm 的小型细胞外囊泡,几乎所有细胞类型均可分泌外泌体。外泌体可携带多种物质,包括 RNA、DNA、脂质、蛋白质和代谢物。外泌体通过在体液中循环,在细胞间传递物质和信息,从而参与人体的多种生理和病理过程。最近的研究将外泌体 microRNAs(miRNAs)与多种人类疾病密切相关,包括糖尿病(DM),这是一种复杂的多因素代谢紊乱疾病。外泌体 miRNAs 是 DM 进展的关键调节因子,主要涉及胰岛β细胞损伤和胰岛素抵抗。外泌体 miRNAs 与 DM 相关并发症密切相关,如糖尿病视网膜病变(DR)、糖尿病肾病(DN)和糖尿病心肌病(DCM)等。深入研究外泌体 miRNAs 的作用机制及其在 DM 中的作用,将有助于深入了解 DM 的病理生理过程。在这里,我们总结了与 DM 相关的外泌体 miRNAs 的最新发现,为分别识别潜在的诊断生物标志物和药物靶点,以进行 DM 的早期诊断和治疗提供了新的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fad/8236118/619fe5da9701/CTM2-11-e468-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fad/8236118/3554aaff33ad/CTM2-11-e468-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fad/8236118/a2230a1eb326/CTM2-11-e468-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fad/8236118/0b5cc8d5cdff/CTM2-11-e468-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fad/8236118/619fe5da9701/CTM2-11-e468-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fad/8236118/3554aaff33ad/CTM2-11-e468-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fad/8236118/a2230a1eb326/CTM2-11-e468-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fad/8236118/0b5cc8d5cdff/CTM2-11-e468-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fad/8236118/619fe5da9701/CTM2-11-e468-g005.jpg

相似文献

1
Emerging roles of exosomal miRNAs in diabetes mellitus.外泌体 miRNAs 在糖尿病中的新兴作用。
Clin Transl Med. 2021 Jun;11(6):e468. doi: 10.1002/ctm2.468.
2
The role of exosome derived miRNAs in inter-cell crosstalk among insulin-related organs in type 2 diabetes mellitus.外泌体衍生的微小RNA在2型糖尿病胰岛素相关器官细胞间串扰中的作用
J Physiol Biochem. 2024 Aug;80(3):501-510. doi: 10.1007/s13105-024-01026-x. Epub 2024 May 3.
3
Exosomal microRNAs in diabetic heart disease.糖尿病性心脏病中的细胞外体 microRNAs。
Cardiovasc Diabetol. 2022 Jul 1;21(1):122. doi: 10.1186/s12933-022-01544-2.
4
Exosomal microRNAs: potential nanotherapeutic targets for diabetic kidney disease.外泌体微小RNA:糖尿病肾病潜在的纳米治疗靶点
Nanomedicine (Lond). 2023 Oct;18(23):1669-1680. doi: 10.2217/nnm-2023-0023. Epub 2023 Nov 1.
5
Exosomal ncRNAs: Novel therapeutic target and biomarker for diabetic complications.外泌体 ncRNAs:糖尿病并发症的新型治疗靶标和生物标志物。
Pharmacol Res. 2022 Apr;178:106135. doi: 10.1016/j.phrs.2022.106135. Epub 2022 Feb 19.
6
Role of Circulating Exosomal miRNA-3976 in Early Diabetic Retinopathy.循环外泌体 miRNA-3976 在早期糖尿病视网膜病变中的作用。
Int J Nanomedicine. 2023 Jul 4;18:3695-3709. doi: 10.2147/IJN.S414393. eCollection 2023.
7
Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.外泌体 miRNAs 作为新型癌症生物标志物:挑战与机遇。
J Cell Physiol. 2018 Sep;233(9):6370-6380. doi: 10.1002/jcp.26481. Epub 2018 Mar 25.
8
Purification and microRNA profiling of exosomes derived from blood and culture media.从血液和培养基中提取的外泌体的纯化及微小RNA分析
J Vis Exp. 2013 Jun 14(76):e50294. doi: 10.3791/50294.
9
Circulating exosomal miRNAs in cardiovascular disease pathogenesis: New emerging hopes.循环外泌体 miRNA 在心血管疾病发病机制中的作用:新的希望。
J Cell Physiol. 2019 Dec;234(12):21796-21809. doi: 10.1002/jcp.28942. Epub 2019 Jul 5.
10
Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer.循环外泌体和外泌体微小RNA作为胃肠道癌的生物标志物
Cancer Gene Ther. 2017 Feb;24(2):48-56. doi: 10.1038/cgt.2016.77. Epub 2016 Dec 16.

引用本文的文献

1
Unlocking the Diagnostic and Therapeutic Potential of microRNA in Diabetes: A Bibliometric and Visualized Analysis (2003-2023).挖掘微小RNA在糖尿病中的诊断和治疗潜力:一项文献计量学与可视化分析(2003 - 2023年)
J Multidiscip Healthc. 2025 Aug 27;18:5227-5247. doi: 10.2147/JMDH.S533519. eCollection 2025.
2
Role of Plasma-Derived Exosomal MicroRNAs in Mediating Type 2 Diabetes Remission.血浆来源的外泌体微小RNA在介导2型糖尿病缓解中的作用
Nutrients. 2025 Jul 27;17(15):2450. doi: 10.3390/nu17152450.
3
Research progress on non-coding RNA regulatory networks and targeted therapy in diabetic nephropathy.

本文引用的文献

1
Therapeutic strategies for miRNA delivery to reduce hepatocellular carcinoma.用于递送微小RNA以降低肝细胞癌的治疗策略。
Semin Cell Dev Biol. 2022 Apr;124:134-144. doi: 10.1016/j.semcdb.2021.04.006. Epub 2021 Apr 26.
2
Exosomal MicroRNAs Mediating Crosstalk Between Cancer Cells With Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in the Tumor Microenvironment.外泌体微小RNA介导肿瘤微环境中癌细胞与癌症相关成纤维细胞及肿瘤相关巨噬细胞之间的串扰
Front Oncol. 2021 Apr 1;11:631703. doi: 10.3389/fonc.2021.631703. eCollection 2021.
3
Restoration of renal TIMP3 levels via genetics and pharmacological approach prevents experimental diabetic nephropathy.
糖尿病肾病中非编码RNA调控网络与靶向治疗的研究进展
Front Endocrinol (Lausanne). 2025 Jul 29;16:1625307. doi: 10.3389/fendo.2025.1625307. eCollection 2025.
4
Exo-hydrogel therapy: a revolutionary approach to managing diabetic complications.外泌体水凝胶疗法:一种治疗糖尿病并发症的革命性方法。
J Nanobiotechnology. 2025 Aug 11;23(1):558. doi: 10.1186/s12951-025-03621-6.
5
Identification of Exosome-Associated Biomarkers in Diabetic Foot Ulcers: A Bioinformatics Analysis and Experimental Validation.糖尿病足溃疡中外泌体相关生物标志物的鉴定:生物信息学分析与实验验证
Biomedicines. 2025 Jul 10;13(7):1687. doi: 10.3390/biomedicines13071687.
6
Exosomal miRNA Profiling in Liquid Biopsy of Vitreous in Proliferative Diabetic Retinopathy.增殖性糖尿病视网膜病变玻璃体液体活检中的外泌体微小RNA分析
Invest Ophthalmol Vis Sci. 2025 Jul 1;66(9):24. doi: 10.1167/iovs.66.9.24.
7
Extracellular vesicles from adipose-derived mesenchymal stem cells prevent high glucose-induced retinal ganglion cell pyroptosis through a microRNA-26a-5p-dependent mechanism.脂肪来源间充质干细胞分泌的细胞外囊泡通过一种依赖微小RNA-26a-5p的机制预防高糖诱导的视网膜神经节细胞焦亡。
J Diabetes Investig. 2025 Jun 26. doi: 10.1111/jdi.70100.
8
Circulating exosome-circRNAs mediated downregulation of FGF9 through ceRNA mechanism aggravates renal fibrosis in diabetic nephropathy.循环外泌体circRNA通过ceRNA机制介导的FGF9下调加重糖尿病肾病中的肾纤维化。
PLoS One. 2025 Jun 17;20(6):e0326217. doi: 10.1371/journal.pone.0326217. eCollection 2025.
9
Effect of miR-29a-3p on renal interstitial fibrosis in diabetic kidney disease through FOXP1-mediated TGF-β1/Smad3 signaling pathway.miR-29a-3p通过FOXP1介导的TGF-β1/Smad3信号通路对糖尿病肾病肾间质纤维化的影响
Cytotechnology. 2025 Jun;77(3):120. doi: 10.1007/s10616-025-00779-7. Epub 2025 Jun 8.
10
A meta-analysis on application and prospect of cell therapy in the treatment of diabetes mellitus.细胞治疗在糖尿病治疗中的应用与前景的荟萃分析。
Stem Cell Res Ther. 2025 May 19;16(1):249. doi: 10.1186/s13287-025-04377-4.
通过基因和药理学方法恢复肾脏 TIMP3 水平可预防实验性糖尿病肾病。
Clin Transl Med. 2021 Feb;11(2):e305. doi: 10.1002/ctm2.305.
4
Circulating Exosomal miRNAs as Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer.循环外泌体 miRNA 作为结直肠癌诊断和预后的生物标志物。
Int J Mol Sci. 2020 Dec 31;22(1):346. doi: 10.3390/ijms22010346.
5
Extracellular vesicles and their potential role inducing changes in maternal insulin sensitivity during gestational diabetes mellitus.细胞外囊泡及其在妊娠期糖尿病期间诱导母体胰岛素敏感性变化中的潜在作用。
Am J Reprod Immunol. 2021 Feb;85(2):e13361. doi: 10.1111/aji.13361. Epub 2021 Feb 10.
6
The emerging role of super enhancer-derived noncoding RNAs in human cancer.超级增强子衍生的非编码 RNA 在人类癌症中的新兴作用。
Theranostics. 2020 Sep 2;10(24):11049-11062. doi: 10.7150/thno.49168. eCollection 2020.
7
Serum miR-29a/b expression in gestational diabetes mellitus and its influence on prognosis evaluation.妊娠期糖尿病患者血清miR-29a/b表达及其对预后评估的影响
J Int Med Res. 2020 Sep;48(9):300060520954763. doi: 10.1177/0300060520954763.
8
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.细胞外囊泡和颗粒生物标志物可定义多种人类癌症。
Cell. 2020 Aug 20;182(4):1044-1061.e18. doi: 10.1016/j.cell.2020.07.009. Epub 2020 Aug 13.
9
Circulating miRNAs as a Predictive Biomarker of the Progression from Prediabetes to Diabetes: Outcomes of a 5-Year Prospective Observational Study.循环微小RNA作为糖尿病前期进展为糖尿病的预测生物标志物:一项5年前瞻性观察研究的结果
J Clin Med. 2020 Jul 10;9(7):2184. doi: 10.3390/jcm9072184.
10
The function and mechanism of circular RNAs in gastrointestinal tumours.环状 RNA 在胃肠肿瘤中的功能与机制。
Cell Prolif. 2020 Jul;53(7):e12815. doi: 10.1111/cpr.12815. Epub 2020 Jun 8.